Mar 2, 2026 08:04AM
Mar 2, 2026 08:00AM
Jan 21, 2026 06:56AM
Jan 14, 2026 04:23AM
Jan 7, 2026 01:17PM
Nov 13, 2025 08:00AM
Oct 13, 2025 05:30AM Barclays Starts Monopar Therapeutics (MNPR) at Overweight
Oct 10, 2025 07:24AM
Oct 6, 2025 05:31AM
Sep 24, 2025 03:53PM
Sep 9, 2025 08:12AM
Aug 12, 2025 08:00AM
Jun 23, 2025 05:03AM
Jun 11, 2025 07:00AM Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
May 13, 2025 08:00AM
Mar 31, 2025 08:00AM
Mar 19, 2025 04:20AM
Nov 11, 2024 07:25AM
Nov 8, 2024 08:00AM
Jun 1, 2023 07:00AM
Jun 1, 2023 07:00AM Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
Mar 27, 2023 05:02PM
Mar 27, 2023 05:00PM
Mar 27, 2023 05:00PM
Oct 5, 2022 08:00AM
Oct 5, 2022 08:00AM
Mar 24, 2022 08:00AM
Mar 24, 2022 08:00AM Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments
Feb 15, 2022 08:05AM
Feb 15, 2022 08:05AM
Feb 15, 2022 08:05AM
Nov 12, 2021 08:00AM
Nov 12, 2021 08:00AM
Oct 27, 2021 08:05AM
Oct 27, 2021 08:05AM Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma
Aug 12, 2021 08:00AM
Aug 12, 2021 08:00AM
Aug 5, 2021 08:00AM
Aug 5, 2021 08:00AM
Aug 3, 2021 08:12AM
Aug 3, 2021 08:00AM
Aug 3, 2021 08:00AM Monopar Announces FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma
May 26, 2021 08:07AM
May 26, 2021 08:00AM
May 26, 2021 08:00AM
May 24, 2021 08:09AM
May 24, 2021 08:00AM
May 24, 2021 08:00AM
May 13, 2021 04:42PM Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates
May 13, 2021 04:42PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All